Toth Financial Advisory’s Precision BioSciences DTIL Stock Holding History

Toth Financial Advisory’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-100	Closed	-$973	–	726
2024 Q2	$973	Hold	100	–	–	﹤0.01%	695
2024 Q1	$1.36K	Buy	+100	New	+$1.22K	﹤0.01%	658
2022 Q1	–	Sell	-7	Closed	-$1K	–	736
2021 Q4	$1K	Hold	7	–	–	﹤0.01%	689
2021 Q3	$2K	Hold	7	–	–	﹤0.01%	642
2021 Q2	$3K	Hold	7	–	–	﹤0.01%	540
2021 Q1	$2K	Hold	7	–	–	﹤0.01%	582
2020 Q4	$2K	Hold	7	–	–	﹤0.01%	526
2020 Q3	$1K	Buy	7 +2	+40%	+$398	﹤0.01%	518
2020 Q2	$1K	Hold	5	–	–	﹤0.01%	499
2020 Q1	$1K	Hold	5	–	–	﹤0.01%	409
2019 Q4	$2K	Hold	5	–	–	﹤0.01%	417
2019 Q3	$1K	Buy	+5	New	+$1.63K	﹤0.01%	445

Other funds holding DTIL

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Toth Financial Advisory's DTIL Position: Q3 2024 in Review

Toth Financial Advisory sold out of Precision BioSciences (DTIL) in Q3 2024, closing a stake of 100 shares — an estimated $973 sold.

Toth Financial Advisory first reported a position in DTIL in Q3 2019 and held it in 12 quarters. The position peaked at $3K in Q2 2021. 51 funds tracked by Wall St. Rank hold DTIL as of Q3 2024.

Toth Financial Advisory reported no remaining Precision BioSciences position as of Q3 2024 after selling out during the quarter.
Toth Financial Advisory sold 100 Precision BioSciences shares in Q3 2024, an estimated $973.
Toth Financial Advisory first reported a position in Precision BioSciences in Q3 2019 and held it in 12 quarters.
Toth Financial Advisory's Precision BioSciences position peaked at $3K in Q2 2021.
51 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2024.

Based on Toth Financial Advisory's 13F filing for Q3 2024, filed 21 Oct 2024.